Advertisement

Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study

      Abstract

      Background

      Albuminuria level is associated with cardiovascular events and mortality in patients with diabetes. However, little is known about the association between albuminuria level in diabetes patients without overt cardiovascular disease. We aimed to examine the association between albuminuria level and the risk of ischemic stroke, myocardial infarction, and all-cause mortality in patients with type 2 diabetes without overt cardiovascular disease.

      Methods

      We linked Danish nationwide registries to identify patients with type 2 diabetes without cardiovascular disease from May 2005 through June 2015. Patients were followed for the outcomes ischemic stroke, myocardial infarction, and all-cause mortality until December 31, 2015. Albuminuria level was based on 2 consecutive measurements of the urinary albumin excretion rate or albumin-to-creatinine ratio. Associations between albuminuria level and incidence of cardiovascular disease and mortality were evaluated with Cox proportional hazard regression.

      Results

      The study population consisted of 69,532 patients with type 2 diabetes without cardiovascular disease. When comparing patients with microalbuminuria to patients with normoalbuminuria, in an analysis adjusted for cardiovascular risk factors, we found hazard ratios of 1.28 (95% confidence interval [CI], 1.07-1.52), 1.34 (95% CI, 1.10-1.62), and 1.48 (95% CI, 1.36-1.61) for ischemic stroke, myocardial infarction, and all-cause mortality, respectively. For macroalbuminuria, the hazard ratios were 1.81 (95% CI, 1.46-2.23), 1.99 (95% CI, 1.59-2.48), and 1.83 (95% CI, 1.64-2.04). Similar results were found after adjusting for concomitant medication.

      Conclusions

      This study showed that albuminuria level is associated with higher risk of incident ischemic stroke, myocardial infarction, and all-cause mortality in Type 2 diabetes patients without overt cardiovascular disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rao Kondapally Seshasai S
        • Kaptoge S
        • Thompson A
        • et al.
        Diabetes mellitus, fasting glucose, and risk of cause-specific death.
        N Engl J Med. 2011; 364: 829-841
        • Sarwar N
        • Gao P
        • et al.
        • Emerging Risk Factors Collaboration
        Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
        Lancet. 2010; 375: 2215-2222
        • American Diabetes Association
        10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019.
        Diabetes Care. 2019; 42: S103-S123
        • Cosentino F
        • Grant PJ
        • Aboyans V
        • et al.
        2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
        Eur Heart J. 2020; 41: 255-323
        • Bouchi R
        • Babazono T
        • Yoshida N
        • et al.
        Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes.
        Hypertens Res. 2010; 33: 1298-1304
        • Miettinen H
        • Haffner SM
        • Lehto S
        • Rönnemaa T
        • Pyörälä K
        • Laakso M
        Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.
        Stroke. 1996; 27: 2033-2039
        • Monseu M
        • Gand E
        • Saulnier P-J
        • et al.
        Acute kidney injury predicts major adverse outcomes in diabetes: synergic impact with low glomerular filtration rate and albuminuria.
        Diabetes Care. 2015; 38: 2333-2340
        • Svensson MK
        • Cederholm J
        • Eliasson B
        • Zethelius B
        • Gudbjornsdottir S
        Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
        Diabetes Vasc Dis Res. 2013; 10: 520-529
        • Al Rawahi AH
        • Lee P
        • Al Anqoudi ZAM
        • et al.
        Cardiovascular disease incidence and risk factor patterns among Omanis with type 2 diabetes: a retrospective cohort study.
        Oman Med J. 2017; 32: 106-114
        • Ninomiya T
        • Perkovic V
        • de Galan BE
        • et al.
        Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
        J Am Soc Nephrol. 2009; 20: 1813-1821
        • Drury PL
        • Ting R
        • Zannino D
        • et al.
        Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
        Diabetologia. 2011; 54: 32-43
        • Viana LV
        • Gross JL
        • Camargo JL
        • Zelmanovitz T
        • da Costa Rocha EPC
        • Azevedo MJ
        Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
        J Diabetes Complications. 2012; 26: 407-412
        • Chen Y-H
        • Chen H-S
        • Tarng D-C
        More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.
        Diabetes Care. 2012; 35: 803-808
        • Fung CSC
        • Wan EYF
        • Chan AKC
        • Lam CLK
        Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
        BMC Nephrol. 2017; 18: 47
        • Zhang X-L
        • Yuan M-X
        • Wan G
        • et al.
        The effects of AER and eGFR on outcomes of CVD in patients with T2DM in an urban community over 8 years of multifactorial treatment: the Beijing Communities Diabetes Study 18.
        Ther Clin Risk Manag. 2018; 14: 1537-1545
        • Jorgensen ME
        • Kristensen JK
        • Reventlov Husted G
        • Cerqueira C
        • Rossing P
        The Danish Adult Diabetes Registry.
        Clin Epidemiol. 2016; 8: 429-434
        • Kildemoes HW
        • Sørensen HT
        • Hallas J
        The Danish National Prescription Registry.
        Scand J Public Health. 2011; 39: 38-41
        • Lynge E
        • Sandegaard JL
        • Rebolj M
        The Danish National Patient Register.
        Scand J Public Health. 2011; 39: 30-33
        • Pedersen CB
        The Danish Civil Registration System.
        Scand J Public Health. 2011; 39: 22-25
        • Levey AS
        • de Jong PE
        • Coresh J
        • et al.
        The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
        Kidney Int. 2011; 80: 17-28
        • Gooley TA
        • Leisenring W
        • Crowley J
        • Storer BE
        Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.
        Stat Med. 1999; 18: 695-706
        • Smulders YM
        • Slaats EH
        • Rakic M
        • Smulders FT
        • Stehouwer CD
        • Silberbusch J
        Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus.
        J Lab Clin Med. 1998; 132: 39-46
        • Phillipou G
        • Phillips PJ
        Variability of urinary albumin excretion in patients with microalbuminuria.
        Diabetes Care. 1994; 17: 425-427
        • Newman DJ
        • Mattock MB
        • Dawnay ABS
        • et al.
        Systematic review on urine albumin testing for early detection of diabetic complications.
        Health Technol Assess. 2005; 9 (iii-4, xiii-163)
        • Watts GF
        • Kubal C
        • Chinn S
        Long-term variation of urinary albumin excretion in insulin-dependent diabetes mellitus: some practical recommendations for monitoring microalbuminuria.
        Diabetes Res Clin Pract. 1990; 9: 169-177
        • Watts GF
        • Taub NA
        • Mazurkiewicz J
        • Shaw KM
        An examination of the covariability of subclinical albuminuria in insulin-dependent diabetes mellitus: implications for monitoring microalbuminuria.
        Diabetes Res Clin Pract. 1993; 21: 177-185
        • Stam F
        • van Guldener C
        • Becker A
        • et al.
        Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
        J Am Soc Nephrol. 2006; 17: 537-545
        • Stehouwer CDA
        • Smulders YM
        Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms.
        J Am Soc Nephrol. 2006; 17: 2106-2111
        • Matsushita K
        • Coresh J
        • Sang Y
        • et al.
        Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
        Lancet Diabetes Endocrinol. 2015; 3: 514-525
        • Yokoyama H
        • Araki S
        • Haneda M
        • et al.
        Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
        Diabetologia. 2012; 55: 1911-1918
        • Cox AJ
        • Hsu F-C
        • Carr JJ
        • Freedman BI
        • Bowden DW
        Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study.
        Cardiovasc Diabetol. 2013; 12: 68
        • Wada T
        • Haneda M
        • Furuichi K
        • et al.
        Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
        Clin Exp Nephrol. 2014; 18: 613-620
        • Piepoli MF
        • Hoes AW
        • Agewall S
        • et al.
        2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representati.
        Atherosclerosis. 2016; 252: 207-274
        • Gaede P
        • Oellgaard J
        • Carstensen B
        • et al.
        Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
        Diabetologia. 2016; 59: 2298-2307
        • Usman M
        • Gillies CL
        • Khunti K
        • Davies MJ
        Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.
        Diabetes Res Clin Pract. 2018; 146: 76-84
        • Saaby L
        • Poulsen TS
        • Hosbond S
        • et al.
        Classification of myocardial infarction: frequency and features of type 2 myocardial infarction.
        Am J Med. 2013; 126: 789-797
        • Johnsen SP
        • Overvad K
        • Sørensen HT
        • Tjønneland A
        • Husted SE
        Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients.
        J Clin Epidemiol. 2002; 55: 602-607
        • Johnson DW
        • Jones GRD
        • Mathew TH
        • et al.
        Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement.
        Med J Aust. 2012; 197: 224-225
      1. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019.
        Diabetes Care. 2019; 42: S124-S138
        • Wu H-Y
        • Peng Y-S
        • Chiang C-K
        • et al.
        Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis.
        JAMA Intern Med. 2014; 174: 1108-1115